Low expectations but maybe something positive is a solid plan for this ticker. There has been a lot of scientific research and chatter concerning adenosine formulations going around from cancer therapies to antiviral platforms and combination drug opportunities. Anything is possible at this time.. it is truly up in the air what is in store for NSPX.
News 
Market Data 
Discover 
